These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 23060584)
21. Molecular profiles of neurofibromatosis type 1-associated plexiform neurofibromas: identification of a gene expression signature of poor prognosis. Lévy P; Bièche I; Leroy K; Parfait B; Wechsler J; Laurendeau I; Wolkenstein P; Vidaud M; Vidaud D Clin Cancer Res; 2004 Jun; 10(11):3763-71. PubMed ID: 15173083 [TBL] [Abstract][Full Text] [Related]
22. Atypical neurofibromas in neurofibromatosis type 1 are premalignant tumors. Beert E; Brems H; Daniëls B; De Wever I; Van Calenbergh F; Schoenaers J; Debiec-Rychter M; Gevaert O; De Raedt T; Van Den Bruel A; de Ravel T; Cichowski K; Kluwe L; Mautner V; Sciot R; Legius E Genes Chromosomes Cancer; 2011 Dec; 50(12):1021-32. PubMed ID: 21987445 [TBL] [Abstract][Full Text] [Related]
23. Peripheral Nerve Sheath Tumors in Patients With Neurofibromatosis Type 1: Morphological and Immunohistochemical Study. Friedrich RE; Nörnberg LKN; Hagel C Anticancer Res; 2022 Mar; 42(3):1247-1261. PubMed ID: 35220215 [TBL] [Abstract][Full Text] [Related]
24. Surgery for Peripheral Nerve Sheath Tumours of the Buttocks, Legs and Feet in 90 Patients With Neurofibromatosis Type 1. Friedrich RE; Tuzcu CT In Vivo; 2021; 35(2):889-905. PubMed ID: 33622881 [TBL] [Abstract][Full Text] [Related]
25. Peripheral nerve tumors in neurofibromatosis 1: An overview on management and indications for surgical treatment in our experience. Garozzo D Neurol India; 2019; 67(Supplement):S38-S44. PubMed ID: 30688231 [TBL] [Abstract][Full Text] [Related]
26. Diagnostic implications of podoplanin expression in peripheral nerve sheath neoplasms. Jokinen CH; Dadras SS; Goldblum JR; van de Rijn M; West RB; Rubin BP Am J Clin Pathol; 2008 Jun; 129(6):886-93. PubMed ID: 18480004 [TBL] [Abstract][Full Text] [Related]
27. Differentially expressed genes in neurofibromatosis 1-associated neurofibromas and malignant peripheral nerve sheath tumors. Holtkamp N; Mautner VF; Friedrich RE; Harder A; Hartmann C; Theallier-Janko A; Hoffmann KT; von Deimling A Acta Neuropathol; 2004 Feb; 107(2):159-68. PubMed ID: 14673600 [TBL] [Abstract][Full Text] [Related]
28. Plexiform neurofibroma with and without associated malignant peripheral nerve sheath tumor: a clinicopathologic and immunohistochemical analysis of 54 cases. McCarron KF; Goldblum JR Mod Pathol; 1998 Jul; 11(7):612-7. PubMed ID: 9688181 [TBL] [Abstract][Full Text] [Related]
29. Telomerase activity is a biomarker for high grade malignant peripheral nerve sheath tumors in neurofibromatosis type 1 individuals. Mantripragada KK; Caley M; Stephens P; Jones CJ; Kluwe L; Guha A; Mautner V; Upadhyaya M Genes Chromosomes Cancer; 2008 Mar; 47(3):238-46. PubMed ID: 18069666 [TBL] [Abstract][Full Text] [Related]
30. Prognostic relevance of FDG PET in patients with neurofibromatosis type-1 and malignant peripheral nerve sheath tumours. Brenner W; Friedrich RE; Gawad KA; Hagel C; von Deimling A; de Wit M; Buchert R; Clausen M; Mautner VF Eur J Nucl Med Mol Imaging; 2006 Apr; 33(4):428-32. PubMed ID: 16404595 [TBL] [Abstract][Full Text] [Related]
31. [Utility of 18 FDG positon emission tomography in detection of sarcomatous transformation in neurofibromatosis type 1]. Bensaid B; Giammarile F; Mognetti T; Galoisy-Guibal L; Pinson S; Drouet A; Combemale P Ann Dermatol Venereol; 2007 Oct; 134(10 Pt 1):735-41. PubMed ID: 17978710 [TBL] [Abstract][Full Text] [Related]
32. Culture of cytogenetically abnormal schwann cells from benign and malignant NF1 tumors. Wallace MR; Rasmussen SA; Lim IT; Gray BA; Zori RT; Muir D Genes Chromosomes Cancer; 2000 Feb; 27(2):117-23. PubMed ID: 10612798 [TBL] [Abstract][Full Text] [Related]
33. Intra-parotid facial nerve multiple plexiform neurofibroma in patient with NF1. Fadda MT; Verdino G; Mustazza MC; Bartoli D; Iannetti G Int J Pediatr Otorhinolaryngol; 2008 May; 72(5):553-7. PubMed ID: 18329107 [TBL] [Abstract][Full Text] [Related]
34. Monitoring of plexiform neurofibroma in children and adolescents with neurofibromatosis type 1 by [ Azizi AA; Slavc I; Theisen BE; Rausch I; Weber M; Happak W; Aszmann O; Hojreh A; Peyrl A; Amann G; Benkoe TM; Wadsak W; Kasprian G; Staudenherz A; Hacker M; Traub-Weidinger T Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28771999 [TBL] [Abstract][Full Text] [Related]
35. Diagnostic delay of NF1 in hemifacial hypertrophy due to plexiform neurofibromas. Overdiek A; Feifel H; Schaper J; Mayatepek E; Rosenbaum T Brain Dev; 2006 Jun; 28(5):275-80. PubMed ID: 16481142 [TBL] [Abstract][Full Text] [Related]
36. The angiogenic factor midkine is aberrantly expressed in NF1-deficient Schwann cells and is a mitogen for neurofibroma-derived cells. Mashour GA; Ratner N; Khan GA; Wang HL; Martuza RL; Kurtz A Oncogene; 2001 Jan; 20(1):97-105. PubMed ID: 11244508 [TBL] [Abstract][Full Text] [Related]
37. Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCR. Lévy P; Vidaud D; Leroy K; Laurendeau I; Wechsler J; Bolasco G; Parfait B; Wolkenstein P; Vidaud M; Bièche I Mol Cancer; 2004 Jul; 3():20. PubMed ID: 15255999 [TBL] [Abstract][Full Text] [Related]
38. Malignant peripheral nerve sheath tumour of the cervical vagus nerve in a neurofibromatosis type 1 patient. Molina AR; Brasch H; Tan ST J Plast Reconstr Aesthet Surg; 2006; 59(12):1458-62. PubMed ID: 17113542 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of F18-deoxyglucose positron emission tomography (FDG-PET) to assess the nature of neurogenic tumours. Cardona S; Schwarzbach M; Hinz U; Dimitrakopoulou-Strauss A; Attigah N; Mechtersheimer section sign G; Lehnert T Eur J Surg Oncol; 2003 Aug; 29(6):536-41. PubMed ID: 12875862 [TBL] [Abstract][Full Text] [Related]
40. Anatomic and metabolic evaluation of peripheral nerve sheath tumors in patients with neurofibromatosis 1 using whole-body MRI and (18)F-FDG PET fusion. Urban T; Lim R; Merker VL; Muzikansky A; Harris GJ; Kassarjian A; Bredella MA; Plotkin SR Clin Nucl Med; 2014 May; 39(5):e301-7. PubMed ID: 24152623 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]